Furthermore, two polymorphisms within the FNDC5 promoter (rs16835198 and rs726344) are both known to impact insulin sensitivity [81], and insulin sensitivity is a contributing factor for developing sarcopenia [82,83]. This evidence concerns the gene INS and sarcopenia.